Projects per year
Personal profile
Education/Academic qualification
Master
Fingerprint
Dive into the research topics where Yven Van Herrewege is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
SchistoSAM: A proof-of-concept trial to evaluate artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children
Bottieau, E., Polman, K., Van Herrewege, Y., Rosanas-Urgell, A., Mbow, M., Cisse, B. & Baert, E.
Flemish Government - Department of Economy, Science & Innovation
1/10/18 → 30/09/22
Project: Research Project
-
TriDoRe: Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?
Lynen, L., de Jong, B., Van Deun, A., Decroo, T., Gumusboga, M., Meehan, C., Lempens, P., Rigouts, L., Ratsarahery, L., Van Herrewege, Y., Buyze, J. & Herssens, N.
Flemish Government - Department of Economy, Science & Innovation
1/10/18 → 30/09/24
Project: Research Project
Research output
-
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial
Van Dijck, C., Tsoumanis, A., Rotsaert, A., Vuylsteke, B., Van den Bossche, D., Paeleman, E., De Baetselier, I., Brosius, I., Laumen, J., Buyze, J., Wouters, K., Lynen, L., Van Esbroeck, M., Herssens, N., Abdellati, S., Declercq, S., Reyniers, T., Van Herrewege, Y., Florence, E. & Kenyon, C., 2021, In : Lancet Infectious Diseases. 21, 5, p. 657-667 11 p.Research output: Contribution to journal › A1: Web of Science-article
-
Chlorhexidine mouthwash fails to eradicate oropharyngeal gonorrhea in a clinical pilot trial (MoNg)
Van Dijck, C., Tsoumanis, A., De Hondt, A., Cuylaerts, V., Laumen, J., Van Herrewege, Y., Florence, E., De Baetselier, I. & Kenyon, C., 2021, In : Sexually Transmitted Diseases.Research output: Contribution to journal › A1: Web of Science-article
-
Evaluation of artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial
Roucher, C., Brosius, I., Mbow, M., Faye, B. T., De Hondt, A., Smekens, B., Arango, D., Burm, C., Tsoumanis, A., Paredis, L., van Herrewege, Y., Potters, I., Cisse, B., Mboup, S., Polman, K. & Bottieau, E., 2021, In : BMJ Open. 11, 6, e047147.Research output: Contribution to journal › A1: Web of Science-article
File11 Downloads (Pure) -
Vaccinating children in high-endemic rabies regions: what are we waiting for?
Soentjens, P., Berens-Riha, N., Van Herrewege, Y., Van Damme, P., Bottieau, E. & Ravinetto, R., 2021, In : BMJ Global Health . 6, 2, 3 p., e004074.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile3 Downloads (Pure) -
Comparative immunogenicity and safety trial of 2 different schedules of single-visit intradermal rabies postexposure vaccination
Soentjens, P., De Koninck, K., Tsoumanis, A., Herssens, N., Van Den Bossche, D., Terryn, S., Van Gucht, S., Van Damme, P., Van Herrewege, Y. & Bottieau, E., 2019, In : Clinical Infectious Diseases. 69, 5, p. 797-804 8 p.Research output: Contribution to journal › A1: Web of Science-article